金钗石斛的菲类抗肿瘤活性成分研究

周威, 曾庆芳, 夏杰, 王鲁, 陶玲, 沈祥春

中国药学杂志 ›› 2018, Vol. 53 ›› Issue (20) : 1722-1725.

PDF(362 KB)
PDF(362 KB)
中国药学杂志 ›› 2018, Vol. 53 ›› Issue (20) : 1722-1725. DOI: 10.11669/cpj.2018.20.004
论著

金钗石斛的菲类抗肿瘤活性成分研究

  • 周威a, 曾庆芳a, 夏杰a, 王鲁b, 陶玲a, 沈祥春a*
作者信息 +

Antitumor Phenanthrene Constituents of Dendrobium nobile

  • ZHOU Weia, ZENG Qing-fanga, XIA Jiea, WANG Lub, TAO Linga, SHEN Xiang-chuna*
Author information +
文章历史 +

摘要

目的 研究金钗石斛药材中的菲类抗肿瘤活性成分。方法 利用各种色谱技术提取分离纯化该药材提取物中的天然产物,并经过波谱方法鉴定化合物结构。采用四甲基偶氮唑蓝(MTT)法、MCF-7乳腺癌细胞, 将单体化合物进行体外抗肿瘤活性研究。结果 从金钗石斛的乙酸乙酯部位分离得到9个化合物,鉴定出菲类化合物4个, 分别为densiflorol B(1)、cypripedin(2)、moscatin(3)、2, 4, 8-三甲氧基菲-3, 7-二醇(4); 香豆素类化合物3个: 香豆素(5)、走马芹内酯(6)、异茴芹内酯(7); 黄酮类化合物1个: 柚皮素(8); 酚类化合物1个:(E)-4-(2-甲氧基乙烯基)苯-1,2-二醇(9)。化合物1~3具有良好的抗肿瘤活性, 它们的IC50值分别为2.99, 5.01和72.68 μmol·L-1结论 化合物6, 7, 9为首次从兰科植物中分离得到, 化合物1,2,4,5,8为首次从该植物中分离得到。化合物1~3可作为抗肿瘤活性候选药物。

Abstract

OBJECTIVE To study the antitumor phenanthrene constituents in Dendrobium nobile. METHODS A variety of chromatographic techniques were applied to extract, isolate and purify natural products from extract of Dendrobium nobile, their structures were identified on the basis of spectral data. The antitumor activity of these monomers in MCF-7 breast cancer cells was studied by MTT assay in vitro. RESULTS Nine compounds were isolated from ethyl acetate part in Dendrobium nobile, there were four phenanthrene compounds, which were densiflorol B(1), cypripedin(2), moscatin(3) and 2,4,8-trimethoxy phenanthrene-3,7-diol(4); three coumarin compounds: coumarin(5), moellendorffiline(6) and isopimpinellin(7); one flavanoid: naringenin(8); one phenol: (E)-4-(2-methoxyvinyl) benzene-1,2-diol(9). Compounds 1-3 had good antitumor activities, their IC50 values were 2.99, 5.01 and 72.68 μmol·L-1 respectively. CONCLUSION The compounds 6, 7, 9 are isolated from the Orchidaceae family for the first time, compounds 1, 2, 4, 5, 8 are isolated from this plant for the first time. Compounds 1-3 can be used as candidates for anti-tumor drugs.

关键词

金钗石斛 / 菲类 / densiflorol B / cypripedin / 抗肿瘤

Key words

Dendrobium nobile / phenanthrene / densiflorol B / cypripedin / antitumor

引用本文

导出引用
周威, 曾庆芳, 夏杰, 王鲁, 陶玲, 沈祥春. 金钗石斛的菲类抗肿瘤活性成分研究[J]. 中国药学杂志, 2018, 53(20): 1722-1725 https://doi.org/10.11669/cpj.2018.20.004
ZHOU Wei, ZENG Qing-fang, XIA Jie, WANG Lu, TAO Ling, SHEN Xiang-chun. Antitumor Phenanthrene Constituents of Dendrobium nobile[J]. Chinese Pharmaceutical Journal, 2018, 53(20): 1722-1725 https://doi.org/10.11669/cpj.2018.20.004
中图分类号: R965   

参考文献

[1] Ch.P(2015)Vol Ⅰ(中国药典2015年版.一部) . 2015: 85-87.
[2] ZHOU W, XIA J, SUN W B, et al. Current research status of chemical constituents and pharmacological effects of Dendrobium nobile. Chin J New Drugs(中国新药杂志), 2017, 26(22): 2693-2700.
[3] DAI Z H, DA F F, ZHU H, et al. Evolution of varieties of Dendrobii caulis in first volume of pharmacopoeia of people's republic of China. Chin Arch Tradit Chin Med(中华中医药学刊), 2017, 35(2): 370-372.
[4] FAN C Q, WANG W, WANG Y P, et al. Chemical constituents from Dendrobium densiflorum. Phytochemistry, 2001, 57: 1255-1258.
[5] SCHMALLE H, HAUSEN B M. A new sensitizing quinone from lady slipper(Cypripedium calceolus). Naturwissenschaften, 1979, 66(10): 527-528.
[6] WANG Y, CHEN S, LU D P, et al. Chemical constituents of Anoectochilus roxburghii. Chin Tradit Herb Drugs(中草药), 2017, 48(13): 2619-2624.
[7] ONO M, ITO Y, MASUOKA C, et al. Antioxidative constituents from dendrobii herba(stems of Dendrobium spp.). Food Sci Technol Res, 1995, 1(2): 115-120.
[8] MO S Y, YANG Y C, SHI J G. Studies on chemical constitutes of Phellinus igniarius. China J Chin Mater Med(中国中药杂志), 2003, 28(4): 339-341.
[9] NIU X M, LI S H, JIANG B, et al. Constituents from the roots of Heracleum rapula franch. J Asian Nat Prod Res, 2002, 4(1): 33-41.
[10] YOO S W, KIM J S, KANG S S, et al. Constituents of the fruits and leaves of Euodia daniellii. Arch Pharm Res, 2002, 25(6): 824-830.
[11] WANG X G, SHEN L T, ZENG Y Y, et al. Flavonoids from Ficus sarmentosa var. henryi. Chin Tradit Herb Drugs(中草药), 2010, 41(4): 526-529.

基金

贵州省国际科技合作计划项目资助; 贵州省特色天然药物资源活性研究科技创新团队资助(4025); 贵州省高等学校科技创新人才团队资助(31);贵州省高层次创新型人才项目“百层次”资助(4029)、“千层次”资助(2016-2018)

PDF(362 KB)

Accesses

Citation

Detail

段落导航
相关文章

/